The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
批准号:
8605737
负责人:
SE-TE JOSEPH HUANG
金额:
$6.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2015-03-31
中文摘要
描述(由申请人提供):植入人细胞滋养层细胞(CTB)侵入由蜕膜细胞和免疫细胞(如巨噬细胞(MF)和树突细胞(DC))组成的下层蜕膜。这些特化的抗原呈递细胞(APC)介导先天免疫,随后激活适应性免疫系统和发展免疫耐受。破坏对病原体的防御和半同种异体胚胎在蜕膜中的耐受性之间的平衡有助于先兆子痫-毒血症(PET),这是围产期和孕产妇发病率和死亡率的主要原因。PET与异常的母体免疫反应有关,这种免疫反应限制了CTB的侵袭,并导致螺旋动脉重塑为大口径低阻力血管受损,而大口径低阻力血管是增加流向发育中的胎儿-胎盘单位的子宫血流所必需的。为了支持这一假设,即过量的流入和激活的MF和DC损害CTB的入侵和促进PET,我们观察到一个显着过量的MF和DC在先兆子痫蜕膜。在无白细胞的早孕期蜕膜细胞中,我们发现促炎细胞因子,肿瘤坏死因子-α(TNF-1)和白细胞介素-1 β(IL-12),显著增强巨噬细胞集落刺激因子(M-CSF),粒细胞-巨噬细胞集落刺激因子(GM-CSF),其将未成熟的MF和DC活化为成熟的MF和DC以及一系列单核细胞/巨噬细胞-和DC-募集趋化因子。我们还发现,从IL-12处理的蜕膜细胞培养的条件培养基增强了巨噬细胞对CTB侵袭的直接抑制。我们的中心假设是,促炎细胞因子通过靶向蜕膜细胞来失调APC的运输和激活,从而有助于免疫调节和PET的发展。为了验证这一假设,我们将1)使用免疫细胞迁移试验鉴定负责募集APC的趋化因子; 2)通过检测效应分子、活化标志物和抗原呈递活性的功能试验来确定M-CSF和GM-CSF是否在活化APC中起作用; 3)通过CTB、APC和内皮细胞的共培养来阐明TNF-1或IL-12处理的蜕膜细胞对CTB侵袭和血管重塑的影响; 4)使用新的MF-或DC-耗尽的PET小鼠模型来评估活化的APC对PET发展的影响。这项工作将有助于更好地了解PET的发病机制,并开发有效的预防和治疗方法来对抗PET。因此,受影响家庭和社会的压力和经济负担将大大减轻。公共卫生相关性:先兆子痫是一种多系统疾病,占所有妊娠的5%至10%,是全球孕产妇和胎儿发病率和死亡率的主要原因。这项研究的免疫学基础先兆子痫将导致新的疗法,以打击这种并发症在怀孕期间。因此,受影响家庭和社会的福利将得到极大改善。
英文摘要
DESCRIPTION (provided by applicant): Implanting human cytotrophoblasts (CTBs) invade an underlying decidua comprised of decidual cells and such immune cells as macrophages (MFs) and dendritic cells (DCs). These specialized antigen-presenting cells (APCs) mediate innate immunity, subsequent activation of the adaptive immune system and in the development of immune tolerance. Perturbation of the balance between defense against pathogens and tolerance of the semi-allogeneic embryo in the decidua contributes to preeclampsia-toxemia (PET), a leading cause of perinatal and maternal morbidity and mortality. PET is associated with an aberrant maternal immune response that restricts CTB invasion and leads to impaired remodeling of the spiral arteries into large bore low resistance vessels necessary to increase uterine blood flow to the developing feto-placental unit. In support of the hypothesis that an excess influx and activation of MFs and DCs impair CTB invasion and promotes PET, we observed a marked excess of MFs and DCs in preeclamptic decidua. In leukocyte-free first trimester decidual cells, we found that the pro-inflammatory cytokines, tumor necrosis factor-a (TNF-1) and interleukin-1 beta (IL-12), profoundly enhanced expression of macrophage-colony stimulating factor (M-CSF), granulocyte- macrophage-colony stimulating factor (GM-CSF), which activate immature MFs and DCs to mature MFs and DCs as well as an array of monocyte/macrophage- and DC-recruiting chemokines. We also found that the direct inhibition of CTB invasion by macrophages was enhanced by conditioned media from IL-12-treated decidual cell culture. Our central hypothesis is that pro-inflammatory cytokines dysregulate trafficking and activation of APCs by targeting decidual cells and, thus, contribute to the immune modulation and the development of PET. To test this hypothesis, we will 1) identify those chemokines responsible for recruiting APCs using immune cell migration assays; 2) determine whether M-CSF and GM-CSF play roles in activating APCs by examining effector molecules, activation markers and functional assays for antigen-presenting activity; 3) elucidate the effects of TNF-1 - or IL-12 -treated decidual cells on CTB invasion and vascular remodeling using co-culture of CTBs, APCs and endothelial cells; 4) use a novel MF- or DC-depleted PET mouse model to evaluate the effects of activated APCs on the development of PET. This work will lead to better understanding of the pathogenesis of PET and the development of effective prevention and therapies to combat PET. Consequently, stress and financial burden for affected family and society will be significantly reduced. PUBLIC HEALTH RELEVANCE: Preeclampsia is a multi-system disorder that complicates 5% to 10% of all pregnancies and is a leading cause of maternal and fetal morbidity and mortality worldwide. This study of the immunological basis of preeclampsia will result in new therapies to combat this complication during pregnancy. Hence, the welfare of affected families and society will be considerably improved.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.thromres.2009.07.012
发表时间:
2009-12
期刊:
Thrombosis research
影响因子:
7.5
作者:
[Li M, Huang SJ]
通讯作者:
Huang SJ
DOI:
10.1016/j.placenta.2011.12.007
发表时间:
2012-03
期刊:
PLACENTA
影响因子:
3.8
作者:
[Wu, Z. -M., Yang, H., Li, M., Yeh, C. -C., Schatz, F., Lockwood, C. J., Di, W., Huang, S. J.]
通讯作者:
Huang, S. J.
Chinese herbal medicine for miscarriage affects decidual micro-environment and fetal growth.
中草药的流产会影响缩减微环境和胎儿生长。
DOI:
10.1016/j.placenta.2015.02.006
发表时间:
2015-05
期刊:
PLACENTA
影响因子:
3.8
作者:
[Piao, L., Chen, C. -P., Yeh, C-C, Basar, M., Masch, R., Cheng, Y-C, Lockwood, C. J., Schatz, F., Huang, S. J.]
通讯作者:
Huang, S. J.
The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
-
批准号:8055262
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2010
-
负责人:SE-TE JOSEPH HUANG
-
依托单位:
The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
-
批准号:7844174
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2009
-
负责人:SE-TE JOSEPH HUANG
-
依托单位:
The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
-
批准号:7466850
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2008
-
负责人:SE-TE JOSEPH HUANG
-
依托单位:
The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
-
批准号:8092646
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2008
-
负责人:SE-TE JOSEPH HUANG
-
依托单位:
The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
-
批准号:7591813
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2008
-
负责人:SE-TE JOSEPH HUANG
-
依托单位:
The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
-
批准号:8242882
-
项目类别:
-
资助金额:$27.16万
-
财政年份:2008
-
负责人:SE-TE JOSEPH HUANG
-
依托单位:
The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
-
批准号:7795261
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2008
-
负责人:SE-TE JOSEPH HUANG
-
依托单位:
海外基金